Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Non-invasive Prenatal Testing (NIPT) Market, by Product
1.4.2 North America Non-invasive Prenatal Testing (NIPT) Market, by Application
1.4.3 North America Non-invasive Prenatal Testing (NIPT) Market, by End User
1.4.4 North America Non-invasive Prenatal Testing (NIPT) Market, by Technology
1.4.5 North America Non-invasive Prenatal Testing (NIPT) Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. North America Non-invasive Prenatal Testing (NIPT) Market by Product
4.1 North America Consumables & Reagents Market by Region
4.2 North America Instruments Market by Region
Chapter 5. North America Non-invasive Prenatal Testing (NIPT) Market by Application
5.1 North America Trisomy Market by Country
5.2 North America Microdeletion Syndrome Market by Country
5.3 North America Others Market by Country
Chapter 6. North America Non-invasive Prenatal Testing (NIPT) Market by End User
6.1 North America Diagnostic Laboratories Market by Country
6.2 North America Hospitals & Clinics Market by Country
Chapter 7. North America Non-invasive Prenatal Testing (NIPT) Market by Technology
7.1 North America Next Generation Sequencing (NGS) Market by Country
7.2 North America Microarray Market by Country
7.3 North America Polymerase Chain Reaction (PCR) Market by Country
7.4 North America Rolling Circular Amplification Market by Country
Chapter 8. North America Non-invasive Prenatal Testing (NIPT) Market by Country
8.1 US Non-invasive Prenatal Testing (NIPT) Market
8.1.1 US Non-invasive Prenatal Testing (NIPT) Market by Product
8.1.2 US Non-invasive Prenatal Testing (NIPT) Market by Application
8.1.3 US Non-invasive Prenatal Testing (NIPT) Market by End User
8.1.4 US Non-invasive Prenatal Testing (NIPT) Market by Technology
8.2 Canada Non-invasive Prenatal Testing (NIPT) Market
8.2.1 Canada Non-invasive Prenatal Testing (NIPT) Market by Product
8.2.2 Canada Non-invasive Prenatal Testing (NIPT) Market by Application
8.2.3 Canada Non-invasive Prenatal Testing (NIPT) Market by End User
8.2.4 Canada Non-invasive Prenatal Testing (NIPT) Market by Technology
8.3 Mexico Non-invasive Prenatal Testing (NIPT) Market
8.3.1 Mexico Non-invasive Prenatal Testing (NIPT) Market by Product
8.3.2 Mexico Non-invasive Prenatal Testing (NIPT) Market by Application
8.3.3 Mexico Non-invasive Prenatal Testing (NIPT) Market by End User
8.3.4 Mexico Non-invasive Prenatal Testing (NIPT) Market by Technology
8.4 Rest of North America Non-invasive Prenatal Testing (NIPT) Market
8.4.1 Rest of North America Non-invasive Prenatal Testing (NIPT) Market by Product
8.4.2 Rest of North America Non-invasive Prenatal Testing (NIPT) Market by Application
8.4.3 Rest of North America Non-invasive Prenatal Testing (NIPT) Market by End User
8.4.4 Rest of North America Non-invasive Prenatal Testing (NIPT) Market by Technology
Chapter 9. Company Profiles
9.1 Illumina, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 Natera Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 SWOT Analysis
9.3 F. Hoffmann-La Roche Ltd.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 SWOT Analysis
9.4 PerkinElmer, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Acquisition and Mergers:
9.4.6 SWOT Analysis
9.5 Laboratory Corporation of America Holdings
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental Analysis
9.5.4 SWOT Analysis
9.6 Eurofins Scientific SE
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Recent strategies and developments:
9.6.4.1 Product Launches and Product Expansions:
9.6.5 SWOT Analysis
9.7 Thermo Fisher Scientific, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 WOT Analysis
9.8 GE HealthCare Technologies, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Product Launches and Product Expansions:
9.8.5.2 Acquisition and Mergers:
9.8.6 SWOT Analysis
9.9 Agilent Technologies, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 SWOT Analysis
9.10. Pacific Biosciences of California, Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 Recent strategies and developments:
9.10.5.1 Acquisition and Mergers:
9.10.6 SWOT Analysis
Unique Offerings 